-
CATALENT PROVIDES A SIMPLIFIED DELIVERY SOLUTION TO SPEED CLINICAL PROOF OF CONCEPTTo help drug development scientists reach their “first dose in man” faster, Catalent Pharma Solutions, LLC has added the Xcelodose® micro-dosing system to its Research Triangle Park (RTP), North C2010/11/10
-
Encompass Announces Exclusive World-Wide Rights to Ocular Delivery SystemEncompass Ophthalmic Development, Inc. recently announced it has secured the exclusive worldwide ophthalmic rights to PROLOC Bioadhesive Ocular Drug Delivery System from the Transdermal and Transmucos2010/11/10
-
Althea Announces Installation of High-Speed Prefilled Syringe LineAlthea Technologies, Inc., a leading provider of development and manufacturing services for biopharmaceuticals and parenteral drug products, recently announced it has completed the installation of a n2010/11/9
-
West Introduces Insert Needle Syringe SystemWest, a global leader in innovative system and component solutions for injectable drug administration, has recently introduced the Daikyo Crystal Zenith 1-mL long insert needle syringe system. The syr2010/11/9
-
Simplified Delivery Solution To Speed Clinical Proof Of ConceptTo help drug development scientists reach their "first dose in man" faster, Catalent Pharma Solutions, LLC has added the Xcelodose micro-dosing system to its Research Triangle Park (RTP), North Caro2010/11/9
-
Selection of new members for the Tenth Chinese Pharmacopoeia Commission startedSelection of new members for the Tenth Chinese Pharmacopoeia Commission started The 2010 edition of Chinese Pharmacopoeia has come into effect as of October 1, 2010. The selection of new members f2010/11/8
-
BASF AND MONSANTO ANNOUNCE PROGRESS IN DICAMBA FORMULATIONSBASF AND MONSANTO ANNOUNCE PROGRESS IN DICAMBA FORMULATIONS For immediate release Media Inquiries: Janice Person, Monsanto Company - +1.901.320.5760 Global queries: Elise Kissling, BASF SE - +42010/11/8
-
SFDA issues The Third National Drug Quality Announcement of 2010SFDA issues The Third National Drug Quality Announcement of 2010 To intensify drug supervision and ensure drug safety for the public, the State Food and Drug Administration (SFDA) organized nation2010/11/5
-
SFDA releases the third issue of 2010 National Medical Device Quality AnnouncementSFDA releases the third issue of 2010 National Medical Device Quality Announcement The State Food and Drug Administration (SFDA) released the third issue of 2010 National Medical Device Quality A2010/11/5
-
ADVENTRX submits NDA for Exelbine to FDAADVENTRX submits NDA for Exelbine to FDA ADVENTRX Pharmaceuticals, Inc. (NYSE Amex: ANX) announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration2010/11/4